Sökning: WFRF:(Hussain Firasat) >
In silicoPotential ...
In silicoPotential of Approved Antimalarial Drugs for Repurposing Against COVID-19
-
- Sachdeva, Cheryl (författare)
- Amity Univ Uttar Pradesh, Amity Inst Virol & Immunol, Sect 25, Noida 201313, Uttar Pradesh, India.
-
- Wadhwa, Anju (författare)
- Univ Delhi, Dept Chem, North Campus,Univ Enclave, Delhi, India.
-
- Kumari, Anita (författare)
- Amity Univ Uttar Pradesh, Amity Inst Virol & Immunol, Sect 25, Noida 201313, Uttar Pradesh, India.
-
visa fler...
-
- Hussain, Firasat (författare)
- Univ Delhi, Dept Chem, North Campus,Univ Enclave, Delhi, India.
-
- Jha, Preeti (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap
-
- Kaushik, Naveen K. (författare)
- Amity Univ Uttar Pradesh, Amity Inst Virol & Immunol, Sect 25, Noida 201313, Uttar Pradesh, India.
-
visa färre...
-
Amity Univ Uttar Pradesh, Amity Inst Virol & Immunol, Sect 25, Noida 201313, Uttar Pradesh, India Univ Delhi, Dept Chem, North Campus,Univ Enclave, Delhi, India. (creator_code:org_t)
- MARY ANN LIEBERT, INC, 2020
- 2020
- Engelska.
-
Ingår i: Omics. - : MARY ANN LIEBERT, INC. - 1536-2310 .- 1557-8100. ; 24:10, s. 568-580
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Although the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is wreaking havoc and resulting in mortality and morbidity across the planet, novel treatments are urgently needed. Drug repurposing offers an innovative approach in this context. We report here new findings on thein silicopotential of several antimalarial drugs for repurposing against COVID-19. We conducted analyses by docking the compounds against two SARS-CoV-2-specific targets: (1) the receptor binding domain spike protein and (2) the main protease of the virus (M-Pro) using the Schrodinger software. Importantly, the docking analysis revealed that doxycycline (DOX) showed the most effective binding to the spike protein of SARS-CoV-2, whereas halofantrine and mefloquine bound effectively with the main protease among the antimalarial drugs evaluated in the present study. Thein silicoapproach reported here suggested that DOX could potentially be a good candidate for repurposing for COVID-19. In contrast, to decipher the actual potential of DOX and halofantrine against COVID-19, furtherin vitroandin vivostudies are called for. Drug repurposing warrants consideration as a viable research and innovation avenue as planetary health efforts to fight the COVID-19 continue.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- COVID-19
- SARS-CoV-2
- drug repurposing
- antimalarial drugs
- drug development
- planetary health
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Omics
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas